Skip to main content

Table 1 Demographic, clinic and laboratory features of the study groups

From: Predictors of epicardial adipose tissue in patients with type 2 diabetes mellitus

Parameters

Diabetic patients (n = 156)

Control group (n = 50)

P value

Age (years)

53.62 ± 9.33

51.06 ± 8.74

0.080

Female/Male

87/69

35/15

0.980

BMI (kg/m2)

31.21 ± 5.87

32.86 ± 7.52

0.159

Waist circumference

103.24 ± 11.29

102.54 ± 11.28

0.702

HbA1c (%)

9.14 ± 2.45

5.50 ± 0.32

<0.001

Disease duration (months)

88.31 ± 75.35

-

-

SBP (mmHg)

135.80 ± 26.97

121.80 ± 16.41

0.001

DBP (mmHg)

74.49 ± 11.43

75.60 ± 11.50

0.553

Total cholesterol (mmol/L)

5.49 ± 1.36

5.61 ± 1.47

0.616

Triglyceride (mmol/L)

2.35 ± 1.55

1.97 ± 1.03

0.052

LDL - cholesterol (mmol/L)

3.39 ± 1.12

3.66 ± 0.85

0.078

HDL - cholesterol (mmol/L)

1.1 ± 0.23

1.23 ± 0.22

<0.001

AIP

0.27 ± 0.30

0.16 ± 0.26

0.012

eGFR (mL/min)

116.76 ± 40.81

126.07 ± 42.42

0.177

Creatinin (mg/dL)

0.82 ± 0.36

0.73 ± 0.16

0.017

EAT (mm)

4.66 ± 1.59

3.91 ± 1.60

0.005

NLR

1.90 ± 0.82

1.45 ± 0.38

<0.001

PLR

116.67 ± 41.62

102.97 ± 35.97

0.027

White blood cell (103/μL)

7.42 ± 2.06

6.77 ± 1.58

0.022

Lymphocyte (103/μL)

2.43 ± 0.73

2.55 ± 0.71

0.296

Neutrophil (103/μL)

4.36 ± 1.59

3.57 ± 0.95

0.001

Platelet (103/mm3)

265.87 ± 67.82

247.52 ± 57.76

0.087

Uric acid (mg/dL)

4.68 ± 1.50

5.30 ± 1.44

0.010

  1. AIP; Atherogenic index of plasma, BMI; body mass index, EAT; epicardial adipose tissue NLR; neutrophils-to-lymphocyte ratio, PLR; Platelet-to-lymphocyte ratio.